NewMRNA

Theraxen is proud to be a partner in the NEWmRNA project, an EU-funded initiative under the Horizon 2020 EIC Pathfinder programme (Grant Agreement No. 965135). This cutting-edge project brings together leading academic and industry partners to explore novel forms of messenger RNA and develop next-generation technologies for its synthesis and application. Our involvement reflects Theraxen’s commitment to advancing RNA-based innovation and contributing to the future of synthetic biology.